A Phase 2 Study of HW211026
Starting soon · Phase 2
Conditions studied: Actinic Keratosis
In brief
This is a multicenter, randomized, open-label, parallel-group, Phase II clinical trial designed to evaluate the efficacy and safety of HW211026 in adult patients with actinic keratosis.
Key facts
- Study ID
- NCT07513454
- Run by
- Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
- People needed
- 80
- Starts
- 2026-07-01
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-07-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Shanghai Skin Disease Hospital — Shanghai, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.